BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Alivus Life Sciences Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
543322
ISIN Demat
INE03Q201024
Book Value (Rs)
271.41036
NSE Symbol
ALIVUS
Divident Yield %
0.36
Market Cap
(Rs In Cr.)
16,866
P/E (TTM)
27.13
EPS (TTM)
50.64
Face Value
(Rs)
2
Back
Alivus Life Sciences standalone net profit rises 9.71% in the December 2025 quarter
22-Jan-26   Hrs IST

Net profit of Alivus Life Sciences rose 9.71% to Rs 150.26 crore in the quarter ended December 2025 as against Rs 136.96 crore during the previous quarter ended December 2024. Sales rose 4.84% to Rs 672.89 crore in the quarter ended December 2025 as against Rs 641.84 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales672.89641.84 5
OPM %34.3729.65 -
PBDT243.71200.31 22
PBT224.05185.15 21
NP150.26136.96 10

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)